Tevard Biosciences

@TevardB

tevard.com

Joined November 2020

499

Following

230

Followers

Replies Reposts Media

Tevard Biosciences
@TevardB
Nov 18, 2025
This month and every month, we stand with the epilepsy community. Founders Daniel Fischer & Warren Lammert, parents of children with Dravet syndrome, are committed to develop therapies that address root causes & bring hope to families. #EpilepsyAwarenessMonth #EndEpilepsy
Tevard Biosciences
@TevardB
Nov 14, 2025
Excited our CSO, Elisabeth Gardiner, is featured in The Medicine Maker on tRNA therapeutics that restore protein in diseases like #DMD and #DCM. Read more: tinyurl.com/yvnrnt35 #Biotech #tRNAtherapy #RareDisease
themedicinemaker.com
Taking on the Genetic Nonsense with tRNAs
Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.
Tevard Biosciences
@TevardB
Nov 4, 2025
Sustainable rare disease drug development requires innovative, scalable approaches. In Pharma’s Almanac Roundtable, our CSO Elisabeth Gardiner, PhD, highlights strategies shaping the future. #Biotech #RareDisease #tRNATherapy #PatientDriven #Innovation #Scalable #DrugDevelopment
Tevard Biosciences
@TevardB
Sep 29, 2025
Tevard CSO Elisabeth Gardiner presented data at FEBS demonstrating the power of Tevard’s suppressor tRNA (suptRNA) platform to rescue full-length, functional proteins in both Duchenne muscular dystrophy (DMD) and dilated cardiomyopathy caused by titin truncations (DCM-TTNtv).
00:00
Tevard Biosciences
@TevardB
Sep 24, 2025
📢 If you’re attending the FEBS Special Meeting in Croatia, don’t miss our CSO Elisabeth Gardiner present exciting new preclinical data showing the transformational potential of our tRNA technology. #GeneticMedicine #tRNA #FEBS